A detailed history of Acadian Asset Management LLC transactions in Vericel Corp stock. As of the latest transaction made, Acadian Asset Management LLC holds 3,530 shares of VCEL stock, worth $200,115. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,530
Holding current value
$200,115
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$42.25 - $53.56 $149,142 - $189,066
3,530 New
3,530 $149,000
Q2 2023

Aug 07, 2023

BUY
$29.0 - $38.37 $30,653 - $40,557
1,057 New
1,057 $39,000
Q2 2020

Aug 12, 2020

SELL
$8.5 - $15.82 $110,942 - $206,482
-13,052 Closed
0 $0
Q1 2020

May 11, 2020

BUY
$7.25 - $19.22 $94,627 - $250,859
13,052 New
13,052 $120,000
Q3 2019

Nov 07, 2019

SELL
$14.93 - $19.83 $561,547 - $745,845
-37,612 Closed
0 $0
Q2 2019

Aug 08, 2019

SELL
$15.01 - $18.89 $1.7 Million - $2.14 Million
-113,324 Reduced 75.08%
37,612 $711,000
Q1 2019

May 09, 2019

SELL
$16.23 - $20.29 $617,437 - $771,892
-38,043 Reduced 20.13%
150,936 $2.64 Million
Q4 2018

Feb 07, 2019

SELL
$10.77 - $18.44 $3.16 Million - $5.41 Million
-293,150 Reduced 60.8%
188,979 $3.29 Million
Q3 2018

Oct 30, 2018

SELL
$9.1 - $14.8 $488,114 - $793,857
-53,639 Reduced 10.01%
482,129 $6.82 Million
Q2 2018

Jul 24, 2018

BUY
$9.6 - $14.6 $2.57 Million - $3.91 Million
268,126 Added 100.18%
535,768 $5.2 Million
Q1 2018

Apr 12, 2018

BUY
$5.7 - $12.3 $1.48 Million - $3.2 Million
260,495 Added 3644.82%
267,642 $2.66 Million
Q4 2017

Jan 18, 2018

SELL
$3.65 - $5.98 $169,557 - $277,794
-46,454 Reduced 86.67%
7,147 $39,000
Q3 2017

Oct 13, 2017

BUY
$3.0 - $6.0 $160,803 - $321,606
53,601
53,601 $321,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.67B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.